Optogenetic vagotomy inhibits reflex bronchoconstriction and cardiac chronotropy

Aubrey B Pierce1, Alexandra B Pincus2, James Kornfield1

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University.

Insights

Optogenetics using halorhodopsin in vagal nerves can inhibit parasympathetic activity. This approach successfully reduced airway hyperreactivity and altered heart rate, demonstrating its utility in studying cardiopulmonary function.

Area of Science:

  • Neuroscience
  • Physiology
  • Genetics

Background:

  • Optogenetics enables targeted control of neural activity.
  • Cre-based mouse lines facilitate studying peripheral nerve roles.
  • Parasympathetic nerves significantly influence homeostasis and disease.

Purpose of the Study:

  • To develop a novel optogenetic tool for inhibiting vagal parasympathetic nerves.
  • To investigate the role of parasympathetic nerves in airway hyperreactivity and cardiac function.

Main Methods:

  • Generated a Choline acetyltransferase (ChAT)-cre mouse line for targeting parasympathetic neurons.
  • Expressed inhibitory halorhodopsin channels in vagal cholinergic nerves.
  • Utilized light stimulation (645 nm) to inhibit nerve activity and assessed responses.

Main Results:

  • Confirmed halorhodopsin expression in parasympathetic neurons via RT-PCR and microscopy.
  • Inhibition of parasympathetic nerves attenuated airway hyperreactivity in house dust mite challenged mice.
  • Inhibition of cardiac cholinergic nerves led to an increased heart rate.

Conclusions:

  • Halorhodopsin is an effective tool for inhibiting parasympathetic nerve activity.
  • This optogenetic strategy aids in dissecting the role of parasympathetic nerves in cardiopulmonary regulation.
  • The developed mouse line offers new possibilities for research in autonomic nervous system disorders.

Related Concept Videos

Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.3K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.8K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K